[go: up one dir, main page]

ES2088431T3 - Preparacion biologica y su utilizacion. - Google Patents

Preparacion biologica y su utilizacion.

Info

Publication number
ES2088431T3
ES2088431T3 ES90912314T ES90912314T ES2088431T3 ES 2088431 T3 ES2088431 T3 ES 2088431T3 ES 90912314 T ES90912314 T ES 90912314T ES 90912314 T ES90912314 T ES 90912314T ES 2088431 T3 ES2088431 T3 ES 2088431T3
Authority
ES
Spain
Prior art keywords
biological preparation
immunoprophilactic
immunoregulator
antigenic
invention describes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90912314T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Application granted granted Critical
Publication of ES2088431T3 publication Critical patent/ES2088431T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Thin Film Transistor (AREA)
  • Recrystallisation Techniques (AREA)

Abstract

LA INVENCION DESCRIBE EL USO DE MATERIAL ANTIGENICO Y/O INMUNOREGULADOR DERIVADO DE "MYCOBACTERIUM VACCAE" PARA EL TRATAMIENTO INMUNOPROFILACTICO CONTRA EL SINDROME DEL SIDA.
ES90912314T 1989-07-28 1990-07-27 Preparacion biologica y su utilizacion. Expired - Lifetime ES2088431T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917256A GB8917256D0 (en) 1989-07-28 1989-07-28 Biological preparation and its use

Publications (1)

Publication Number Publication Date
ES2088431T3 true ES2088431T3 (es) 1996-08-16

Family

ID=10660759

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90912314T Expired - Lifetime ES2088431T3 (es) 1989-07-28 1990-07-27 Preparacion biologica y su utilizacion.

Country Status (13)

Country Link
EP (1) EP0484438B1 (es)
JP (1) JPH05500803A (es)
AT (1) ATE136467T1 (es)
AU (1) AU644376B2 (es)
CA (1) CA2064029C (es)
DE (1) DE69026506T2 (es)
DK (1) DK0484438T3 (es)
ES (1) ES2088431T3 (es)
FI (1) FI920356A0 (es)
GB (1) GB8917256D0 (es)
NO (1) NO920331L (es)
WO (1) WO1991001751A1 (es)
ZA (1) ZA905927B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
DK0556248T3 (da) * 1990-11-08 1997-10-27 Univ London Mycobacterium som adjuvans til antigener
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA77666C2 (en) * 2001-01-17 2007-01-15 Kabulesh Mafatlal Khamar Use of mycobacterium w or its components in preparations for treating hiv infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen

Also Published As

Publication number Publication date
NO920331D0 (no) 1992-01-24
CA2064029C (en) 1998-12-29
AU644376B2 (en) 1993-12-09
ATE136467T1 (de) 1996-04-15
CA2064029A1 (en) 1991-01-29
DE69026506T2 (de) 1996-09-12
EP0484438A1 (en) 1992-05-13
FI920356A0 (fi) 1992-01-27
DE69026506D1 (de) 1996-05-15
JPH05500803A (ja) 1993-02-18
WO1991001751A1 (en) 1991-02-21
NO920331L (no) 1992-01-24
AU6188390A (en) 1991-03-11
GB8917256D0 (en) 1989-09-13
ZA905927B (en) 1991-05-29
DK0484438T3 (da) 1996-06-10
EP0484438B1 (en) 1996-04-10

Similar Documents

Publication Publication Date Title
ZA908953B (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ES2088431T3 (es) Preparacion biologica y su utilizacion.
FR2669932B1 (fr) Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
GB9024320D0 (en) Treatment of uveitis
ES2177638T3 (es) Uso de mycobacterium para el tratamiento de tumores.
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
ES2125331T3 (es) Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
DE69034166D1 (de) Azellulärer Impfstoff
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
ES2081878T3 (es) Procedimiento para la preparacion discontinua de l-carnitina por via microbiologica.
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
ES2018613B3 (es) Procedimiento y dispositivo para la depuracion de aguas contaminadas.
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
FR2680714B1 (fr) Unites de maintien et de calage et ensemble forme de telles unites.
ES516819A0 (es) Procedimiento perfeccionado e instalacion correspondiente para el tratamiento terciario fotobiologico de aguas residualees.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.
ES1011387Y (es) Protesis para el tratamiento y recuperacion de miembros inferiores.
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 484438

Country of ref document: ES